A trauma-informed approach to help Black women start PrEP
Part of Infections, Mental health, Women’s health & pregnancy clinical trials.
This study tests a program that helps Black women start PrEP (a daily pill to prevent HIV). It focuses on understanding and addressing past trauma to make it easier to take PrEP, and is designed for women who have not used PrEP before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Black cisgender woman (assigned female at birth and identify as a woman).
- You are HIV-negative (no HIV infection).
- You are 18 years or older.
- In the past 6 months, you had vaginal or anal sex without a condom with a male partner.
- You have at least one risk factor for HIV, like a partner with HIV, a recent sexually transmitted infection, or having multiple sex partners.
- You have never taken PrEP (the HIV prevention pill).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized care coordination program to help Black men who have sex with men stay on HIV prevention. It focuses on men who are new to or have stopped PrEP and want to reduce their HIV risk.
This study tests ways to help Black cisgender women take PrEP, a daily pill that prevents HIV infection. It focuses on making PrEP work for you.
This study tests whether watching short videos can help Black women learn about and start PrEP, a daily pill that prevents HIV, and also helps their healthcare providers support them. It may be a good fit if you are a Black woman interested in learning more about HIV prevention.
This trial tests a digital toolkit to help women start taking PrEP, a medication that prevents HIV. It looks at whether the toolkit makes it easier for women to take PrEP consistently.
This study looks at how to help Black men who have sex with men stick with PrEP, a daily pill that prevents HIV. We want to see if extra counseling and support helps you keep taking PrEP as prescribed.
This study asks people who may use PrEP—an HIV prevention medicine—about their decision to start, not start, or stop PrEP. It aims to understand needs and barriers so PrEP can work better for cisgender women and transgender people who are considering it.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.